ClearView Investor Presentation Year Ended 30 June 2024

Balance sheet as at 30 June 2024 (AASB 17)

30 Jun 2024 30 Jun 2023 Restated

Consolidated Balance Sheet (shareholder view) 1

Commentary 2 Net Asset and Capital Position • Net assets of $353.2m, post $9.9m HY24 interim cash dividend and FY23 final cash dividend of $19.8m • Stated after AASB 17 Opening Balance Sheet net of tax adjustment of $83.6m • Surplus capital above internal benchmarks of $27.1m 7 Cash, debt and investments • Net cash and investments position of $418.1m • Cash and cash equivalents of $101.3m • $422.3m invested in PIMCO income securities portfolio • $31m drawn down under $60m debt facility • $74.5m Tier 2 subordinated debt • Proceeds from sale of interest in Centrepoint Alliance in November 2023 ($15.2m) Goodwill and intangibles • Goodwill of $4m supported by life insurance CGU. Wealth management goodwill of $8.5m impaired in FY24 • Intangibles of $31.7m relates to capitalised software costs associated with life insurance systems development – wealth management software costs of $2.9m impaired in FY24 Life Insurance contract liability • Life Insurance contract liability reflects (re)insurance contract liabilities net of (re)insurance contract assets in accordance with AASB 17

Assets Cash and cash equivalent

101.3 422.3

116.9 393.7

Investments

Investments in associate

0.0

13.4 22.4

Receivables

31.4

Assets held for sale 6 Deferred tax asset

0.0

6.7

48.9

46.7

Property, plant & equipment

0.7 4.9 4.0

0.6 7.8

Right of use asset

Goodwill

12.5 27.0

Intangibles Total assets Liabilities Payables

31.7

645.2

647.7

10.6

20.3 17.6

Current tax liability

6.0 5.6 5.4

Lease liability

8.6 7.8

Provisions

Life insurance 3

157.8

109.2

Borrowings 4

31.0 74.5

16.0 74.2

Subordinated debt 5 Deferred tax liabilities

1.1

0.6

292.0 353.2

254.3 393.4

Total liabilities

Net assets

1. Management view excludes the life investment contracts (that is,unit linked business). 2. As at 30 June 2024 unless otherwise stated 3. Life Insurance liability reflects (re)insurance contract liabilities net of (re)insurance contract assets in accordance with AASB 17. 4. ClearView has access to a $60m debt funding facility, $31m drawn at 30 June 2024. 5. ClearView raised $75m (net of $0.5m of costs) of Tier 2 capital in November 2020. 6. Assets held for sale represent net assets of CFML, net of costs to sell at 30 June 2023. CFML sale completed on 31 January 2024. 7. Net capital position of $27.1m as at 30 June 2024. Stated after payment of cash dividends in FY24 (-$29.7m) but prior to final FY24 dividend. Stated after capital release from the wealth management exit ($5.9m) and capital benefit from sale of shares in Centrepoint Alliance in November 2023 ($5.2m). Includes benefits from review of target capital and related items (+$20.3m)

32

Powered by